Zoledronic acid increases bone density but does not reduce fractures in frail elderly people, study finds

A single intravenous dose of the osteoporosis drug zoledronic acid has been found to increase bone mineral density in a group of frail elderly women living in nursing homes and long term care facilities, but it did not reduce the incidence of fractures over a two year period.